REG - Inspiration Health - Purchasing agreement in the US

Inspiration HealthcareAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260128:nRSb6024Qa&default-theme=true

RNS Number : 6024Q  Inspiration Healthcare Group PLC  28 January 2026

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Purchasing agreement in the US

Partnership accelerates Airon's US expansion

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, announces that its US subsidiary, Airon Corporation ("Airon"), has
entered into a significant new three-year purchasing agreement with a large US
healthcare provider. This marks an important milestone for Airon's continued
expansion in the US market.

 

Under the terms of the agreement, Airon will receive an initial order for 150
units of its Model A and Neo ventilators and accessories, reflecting a
significant expansion to its installed base in the US.

 

This contract delivers a new long-term high quality revenue stream for Airon
and directly supports Inspiration Healthcare's strategic goal of doubling
Airon revenue within five years. Beyond initial equipment sales, the agreement
includes expectations for ongoing consumables and service revenue,
substantially increasing the lifetime value of the partnership.

 

Raffi Stepanian, CEO of Inspiration Healthcare, said: "This agreement
validates our technology and execution capabilities on a national scale and is
a transformative moment for Airon and for Inspiration Healthcare's US
ambitions. We are pursuing further similar opportunities as part of our growth
strategy for Airon."

 

Enquiries:

 

 Inspiration Healthcare Group plc                                                      Tel: +44 (0)330
                                                       175 0000
 Raffi Stepanian, Chief Executive Officer
 Alan Olby, Chief Financial Officer

 Panmure Liberum (Nominated Adviser & Broker)                                                                                                    Tel: +44 (0)20
                                                                                                                 3100 2000
 Will Goode

 Emma Earl
 Mark Rogers

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
                                   (mailto:inspirationhealthcare@walbrookpr.com)
 Anna Dunphy                                           Mob: +44 (0) 7876 741 001
 Rachel Broad                                          Mob: +44 (0) 7747 515 393

 

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets
pioneering medical technology. Based in the UK, the Company specialises in
neonatal intensive care medical devices, which are addressing a critical need
to help to save the lives and improve the outcomes of patients, starting with
the very first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy.  In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.

 

The Company operates in the UK from its world-class Manufacturing and
Technology Centre in Croydon, South London and in the USA from its facility in
Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found
at www.inspirationhealthcaregroup.com
(http://www.inspirationhealthcaregroup.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGREAKFXAEXKEFA



            Copyright 2019 Regulatory News Service, all rights reserved